Last reviewed · How we verify
NCT06102135
Acceptability and Tolerance Study of Peptide Feed with Fibre
NA trial testing Peptamen 1.3 PHGG in Dietary Exposure in 15 participants. Completed in 3 September 2024.
3 September 2024
Quick facts
| Lead sponsor | Société des Produits Nestlé (SPN) |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 15 |
| Start date | 5 September 2023 |
| Primary completion | 3 September 2024 |
| Estimated completion | 3 September 2024 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Peptamen 1.3 PHGG
Conditions studied
- Dietary Exposure — all drugs for Dietary Exposure →
Sponsor
Société des Produits Nestlé (SPN) — full company profile →
Who can join
18 and older, any sex, with Dietary Exposure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Enterally fed adults with documented evidence of gastrointestinal intolerance will be recruited. Participants will be deemed by the investigator as having a clinical indication for enteral feeding with a fibre containing peptide formula. Data from 15 participants are required in order to submit an application to the Advisory Committee on Borderline Substances (ACBS) for product registration.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06102135
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dietary Exposure
Currently open trials in the same condition.
- NCT06526169 — Assessment of Human Exposure to Chemical Hazards · active not recruiting
- NCT06459661 — The Bowel Movement Monitoring (BoMoMo) Study · recruiting
- NCT06323538 — Cohort Study on Plant-based Diets (COPLANT Study) · recruiting
- NCT05763992 — Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach · Phase 2 · recruiting
- NCT06449170 — Discovery of Biomarkers of Intake of of Highly Consumed Foods in Mexico · NA · active not recruiting
Other Société des Produits Nestlé (SPN) trials
Trials by the same sponsor.
- NCT07312201 — Oral Nutritional Supplementation in Children With Growth Concerns · NA · not yet recruiting
- NCT07378111 — Vegetarian Tube Feed Study · NA · not yet recruiting
- NCT07439718 — The Effects of an Oral Nutritional Intervention on the Small Intestine Microbiome · NA · recruiting
- NCT07341464 — Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends · NA · recruiting
- NCT07127198 — Tolerance and Appetite Reduction of a Nutritional Solution With Intragastric Gelation Properties · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06102135 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Société des Produits Nestlé (SPN)
- Last refreshed: 23 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06102135.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing